Commonly reported side effects of lurasidone include: psychomotor retardation, akathisia, basal ganglia disease, bradykinesia, cogwheel rigidity, drowsiness, hypokinesia, muscle rigidity, nausea, parkinson's disease, sedation, tremor, altered serum glucose, and drooling.
Other side effects include: oculogyric crisis, trismus, agitation, anxiety, dystonia, torticollis, increased serum prolactin, and weight gain.
See below for a comprehensive list of adverse effects.
The most commonly reported adverse events included somnolence, akathisia, extrapyramidal symptoms, and nausea.
Common (1% to 10%): Increase weight, increased appetite, decreased appetiteFrequency not reported: Increase in blood sugar levels
In uncontrolled, long-term schizophrenia trials, this drug was associated with a mean increase in glucose from baseline of 1.
8 mg/dL at 24 weeks, 0.
8 mg/dL at 36 weeks, and 2.
3 mg/dL at 52 weeks.
Similar results were observed in bipolar depression studies.
The proportion of lurasidone-treated patients with a 7% or greater increase in body weight was 4.
8% (compared with 3.
3% for placebo).
Pooled data from short-term trials showed a mean weight gain of 0.
43 kg in lurasidone-treated patients (compared with -0.
2 kg in placebo).
Very common (10% or more): Nausea (up to 17%)Common (1% to 10%): Vomiting, dyspepsia, salivary hypersecretion, dry mouth, diarrheaUncommon (0.
1% to 1%): Abdominal pain, diarrheaRare (less than 0.
1%): GastritisFrequency not reported: Dysphagia
Very common (10% or more): Somnolence (up to 26%), akathisia (up to 22%), extrapyramidal disorder (up to 22%)Common (1% to 10%): Dizziness, dystoniaUncommon (0.
1% to 1%): Cerebrovascular accident, dysarthria, seizuresFrequency not reported: Neuroleptic malignant syndrome, gait disturbance
Akathisia and extrapyramidal symptoms were dose-related.
Very common (10% or more): Insomnia (11%)Common (1% to 10%): Agitation, anxiety, restlessnessUncommon (0.
1% to 1%): Abnormal dreams, panic attack, sleep disorder, suicidal ideation, activation of mania/hypomania, catatoniaFrequency not reported: Panic attack, sleep disorder
Uncommon (0.
1% to 1%): AnemiaRare (less than 0.
1%): EosinophiliaFrequency not reported: Leukopenia, neutropenia
Common (1% to 10%): Tachycardia, hypertensionUncommon (0.
1% to 1%): AV block 1st degree, angina pectoris, bradycardia, orthostatic hypotension, hypotensionRare (less than 0.
1%): SyncopeFrequency not reported: Bradycardia
In short-term trials, orthostatic hypotension and syncope were reported in 0.
3% and 0.
1% (n=1508) of patients in schizophrenia studies.
There were no reports in the bipolar depression monotherapy trials.
ECG measurements taken at various points during clinical trials found no QT prolongations exceeding 500 milliseconds (ms) including a subset of patients defined as having an increased cardiac risk.
In a dedicated QT study in clinically stable patients with schizophrenia or schizoaffective disorder (n=87), the maximum mean increase in QTc was 0.
36 ms and 1.
69 ms for a 120 mg and 600 mg dose, respectively.
No patient experienced a QTc increase of greater than 60 ms from baseline and no patient experienced a QTc greater than 500 ms.
Common (1% to 10%): Back pain, increased creatinine phosphokinaseUncommon (0.
1% to 1%): Joint stiffness, myalgia, neck painRare (less than 0.
1%): Rhabdomyolysis
Common (1% to 10%): Rash, pruritusUncommon (0.
1% to 1%): HyperhidrosisRare (less than 0.
1%): Angioedema
Common (1% to 10%): Urinary tract infectionUncommon (0.
1% to 1%): Dysuria, amenorrhea, dysmenorrheaRare (less than 0.
1%): Erectile dysfunction
Common (1% to 10%): Elevated serum creatinineRare (less than 0.
1%): Renal failure
In schizophrenia studies, the proportion of patients with prolactin elevations 5 times the upper limit of normal (5 x ULN) or greater was 2.
8% compared with 1% in placebo.
The proportion of female patients and male patients with elevations of 5 x ULN or greater was 5.
7% and 1.
6%, respectively.
Common (1% to 10%): Elevated prolactin levelsRare (less than 0.
1%): Breast enlargement, breast pain, galactorrhea
Uncommon (0.
1% to 1%): Alanine aminotransferase increased
Postmarketing reports: Hypersensitivity
Common (1% to 10%): Influenza
Common (1% to 10%): Blurred vision
Common (1% to 10%): FatigueUncommon (0.
1% to 1%): VertigoRare (less than 0.
1%): Sudden deathFrequency not reported: Drug withdrawal syndrome neonatal
Common (1% to 10%): Nasopharyngitis
Absence of or decrease in body movement
difficulty with swallowing
drooling
inability to sit still
incremental or ratchet-like movement of the muscle
loss of balance control
mask-like face
muscle discomfort
muscle trembling, jerking, or stiffness
need to keep moving
restlessness
rigid or stiff muscles
shakiness in the legs, arms, hands, or feet
shuffling walk
slow movements
slow reflexes
slurred speech
stiffness of the arms and legs
tic-like (jerky) movements of the head, face, mouth, and neck
trembling or shaking of the hands or feet
twisting movements of the body
uncontrolled movements, especially of the face, neck, and back
Arm, back, or jaw pain
blurred vision
burning while urinating
changes in patterns and rhythms of speech
chest pain or discomfort
chills
cold sweats
confusion
convulsions
difficult or painful urination
difficulty opening the mouth
difficulty with breathing
dizziness
dizziness, faintness, or lightheadedness when getting up from a lying or sitting position
fast, pounding, or irregular heartbeat or pulse
fixed position of the eye
headache
high fever
inability to move the eyes
inability to speak
increased blinking or spasms of the eyelid
increased sweating
lockjaw
loss of bladder control
muscle spasm, especially of the neck and back
nervousness
pale skin
pounding in the ears
seizures
severe muscle stiffness
severe or sudden headache
shortness of breath
slow or fast heartbeat
slurred speech
sticking out of the tongue
sweating
temporary blindness
tiredness
trouble with breathing, speaking, or swallowing
troubled breathing with exertion
uncontrolled twisting movements of the neck, trunk, arms, or legs
unusual bleeding or bruising
unusual facial expressions
unusual tiredness or weakness
unusually pale skin
weakness in the arm or leg on one side of the body, sudden and severe
Black, tarry stools
bloody urine
breast pain or swelling
cough
dark-colored urine
decreased frequency or amount of urine
fever
increased thirst
large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
loss of appetite
lower back or side pain
muscle cramps or spasms
muscle pain or stiffness
nausea
sore throat
sores, ulcers, or white spots on the lips or in the mouth
swelling of the face, fingers, or lower legs
swollen glands
troubled breathing
vomiting
weight gain 
Acid or sour stomach
anxiety
belching
drowsiness
dry mouth
heartburn
hyperventilation
indigestion
irritability
relaxed and calm
sleepiness or unusual drowsiness
sleeplessness
stomach discomfort, upset, or pain
trouble sleeping
unable to sleep
unusually deep sleep
unusually long duration of sleep
Abnormal dreams
anxiety
back pain
blurred vision
burning feeling in the chest or stomach
decreased appetite
diarrhea
feeling of constant movement of self or surroundings
indigestion
itching
sensation of spinning
skin rash
sweating
tenderness in the stomach area
watering of mouth and drooling
Decreased interest in sexual intercourse
inability to have or keep an erection
loss in sexual ability, desire, drive, or performance
unexpected or excess milk flow from the breasts